Itau Unibanco Holding S.A. Recursion Pharmaceuticals, Inc. Transaction History

Itau Unibanco Holding S.A.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$7.35 - $10.05 $12,906 - $17,647	1,756 New	1,756 $13,000
Q4 2023 Feb 14, 2024	BUY	$5.09 - $10.79 $16,089 - $34,107	3,161 New	3,161 $31,000
Q4 2022 Feb 09, 2023	BUY	$7.16 - $12.7 $15,308 - $27,152	2,138 New	2,138 $16,000
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.26 $10,825 - $19,890	2,148 Added 84.9%	4,678 $38,000
Q4 2021 Feb 14, 2022	BUY	$16.14 - $21.86 $40,834 - $55,305	2,530 New	2,530 $44,000

348

284M

2.83M

3.64M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.03B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Itau Unibanco Holding S.A. with notifications on news.